Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
182
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

303
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
303
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

Blood·2026
Same author

Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies.

Cytotherapy·2025
Same author

Decoding carbapenem resistant organisms (CROs) causing lower respiratory tract infections & their antimicrobial susceptibility pattern.

The Indian journal of medical research·2025
Same author

Design of an integrated multi-modal machine learning framework for real-time student engagement evaluation and learning outcome optimizations.

MethodsX·2025
Same author

Predictive modeling of adolescent suicidal behavior using machine learning: Key features and algorithmic insights.

MethodsX·2025
Same author

Deep reinforced cognitive analytics algorithm (DRCAM): An advanced method to early detection of cognitive skill impairment using deep learning and reinforcement learning.

MethodsX·2025

Related Experiment Video

Updated: Sep 18, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Early detection of cognitive decline with deep learning and graph-based modeling.

Sunita Patil1, Swetta Kukreja1

  • 1Computer Science and Engineering, Amity School of Engineering and Technology, Mumbai, Maharashtra 410206, India.

Methodsx
|June 26, 2025
PubMed
Summary

This study presents a new framework for early cognitive impairment detection using deep learning and multimodal data. It enhances accuracy and personalization for timely intervention in cognitive health.

Keywords:
Cognitive Anomaly Detection and Adaptive Chatbot ResponseCognitive assessmentDeep learningGraph neural networksMultimodal fusion

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Related Experiment Videos

Last Updated: Sep 18, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Computational Health

Background:

  • Rising stress and depression impact cognitive well-being, necessitating early detection of cognitive impairment.
  • Traditional cognitive assessments like the Montreal Cognitive Assessment (MOCA) have limitations in adaptability.
  • A dynamic, data-driven approach is crucial for modern cognitive health assessment.

Purpose of the Study:

  • To introduce a Multimodal Fusion Cognitive Assessment Framework for enhanced early identification of cognitive impairment.
  • To develop a scalable, personalized, and adaptive cognitive assessment system.
  • To improve early detection and support targeted intervention strategies for cognitive health.

Main Methods:

  • Integration of Multimodal Deep Learning, including MOCA scores, behavioral data, speech signals, and physiological parameters.
  • Utilizing Graph Attention Networks (GAT), Transformer Attention (TAT), and Convolutional Neural Network-Long Short-Term Memory (CNN-LSTM) models.
  • Employing Information Fusion via Heterogeneous Graph Neural Networks (GNNs) for cross-domain data merging.
  • Application of Reinforcement Learning (RL) for personalized user interaction based on real-time cognitive and stress cues.

Main Results:

  • The proposed model achieves superior performance in cognitive state assessment through effective inter-modality learning.
  • Heterogeneous GNNs successfully merge diverse data sources for a holistic cognitive evaluation.
  • Reinforcement Learning personalizes interactions, reducing cognitive overload and enhancing user engagement.

Conclusions:

  • The Multimodal Fusion Cognitive Assessment Framework significantly enhances early detection accuracy for cognitive impairment.
  • This data-driven approach offers a more dynamic and personalized alternative to traditional cognitive tests.
  • The framework supports timely interventions and improved management of cognitive health in the modern world.